Original Article
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
Mizuki Kobayashi,
Shintaro Narita,
Yoshiyuki Matsui,
Souhei Kanda,
Yu Hidaka,
Hiroyasu Abe,
Toyonori Tsuzuki,
Katsuhiro Ito,
Takahiro Kojima,
Minoru Kato,
Shingo Hatakeyama,
Yuto Matsushita,
Sei Naito,
Masanobu Shiga,
Makito Miyake,
Yusuke Muro,
Shotaro Nakanishi,
Yoichiro Kato,
Tadamasa Shibuya,
Tetsutaro Hayashi,
Hiroaki Yasumoto,
Takashi Yoshida,
Motohide Uemura,
Rikiya Taoka,
Manabu Kamiyama,
Satoshi Morita,
Tomonori Habuchi,
Osamu Ogawa,
Hiroyuki Nishiyama,
Hiroshi Kitamura,
Takashi Kobayashi,
the Japan Urological Oncology Group,
Kensuke Hikami,
Takeshi Yamada,
Kosuke Ogawa,
Kenji Nakamura,
Naoto Sassa,
Akira Yokomizo,
Takashige Abe,
Kazunari Tsuchihashi,
Shuichi Tatarano,
Junichi Inokuchi,
Ryotaro Tomida,
Maki Fujiwara,
Atsushi Takahashi,
Kazumasa Matsumoto,
Kosuke Shimizu,
Hiromasa Araki,
Ryoma Kurahashi,
Yu Ozaki,
Yu Tashiro,
Masayuki Uegaki,
Satoru Maruyama,
Shoichiro Mukai,
Masakazu Tsutsumi,
Jun Miki,
Tomoya Okuno,
Yuko Yoshio,
Hiroaki Matsumoto,
Toru Shimazui,
Takehiko Segawa,
Takashi Karashima,
Kimihiko Masui,
Fumimasa Fukuta,
Kojiro Tashiro,
Kazuto Imai,
Shigetaka Suekane,
Seiji Nagasawa,
Shin Higashi,
Tomohiro Fukui
No similar elements